您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览39 | 下载0

Background::Current guidelines recommend hepatocellular carcinoma (HCC) screening in high-risk populations. However, the ideal HCC screening interval and screening modality have not been determined. This study aimed to compare the screening efficacy among different modalities with various intervals.Methods::PubMed and other nine databases were searched through June 30, 2021. Binary outcomes were pooled using risk ratio (RR) with 95

作者:Yang Jichun;Yang Zhirong;Zeng Xueyang;Yu Shuqing;Gao Le;Jiang Yu;Sun Feng

来源:中华医学杂志英文版 2023 年 136卷 11期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:39 | 下载:0
作者:
Yang Jichun;Yang Zhirong;Zeng Xueyang;Yu Shuqing;Gao Le;Jiang Yu;Sun Feng
来源:
中华医学杂志英文版 2023 年 136卷 11期
标签:
Hepatocellular carcinoma Screening interval Screening modality Effectiveness Systematic review Meta-analysis Hepatocellular carcinoma Screening interval Screening modality Effectiveness Systematic review Meta-analysis
Background::Current guidelines recommend hepatocellular carcinoma (HCC) screening in high-risk populations. However, the ideal HCC screening interval and screening modality have not been determined. This study aimed to compare the screening efficacy among different modalities with various intervals.Methods::PubMed and other nine databases were searched through June 30, 2021. Binary outcomes were pooled using risk ratio (RR) with 95